Skip to content

BD Diagnostics (Geneohm Sciences, Inc.)

Also registered as Bd Diagnostics (Geneohm Sciences Canada, Inc)

United StatesFDA applicant, unverified

Devices
4
FDA recalls
3

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA recalls

Catalogue4

Newest first, rows 1-4 of 4

  • Bd Geneohm Cdiff Assay Ref K081920

    Active Regimes: 510(k) Registry: 510(k) Class:I
  • Bd Max Mrsa Assay, Bd Max Instrument Ref K120138 Open recall

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Bd Geneohm Staphsr Assay Ref K071026

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Bd Geneohm Mrsa Acp Assay Ref K093346

    Active Regimes: 510(k) Registry: 510(k) Class:II

FDA recalls3

Recalls are matched to the firm by name. FDA recall data as of 22 Oct 2026.

  • 2008

    • 11 Nov 2008 Z-1963-2009 Unclassified (pre-2012) Terminated BD Diagnostics GeneOhm (BDDG) has determined that the Cepheid SmartCycler reaction tubes packaged in the BD GeneOhm MRSA test kits identified above may be defective. Distribution: Worldwide Distribution -- US (CA, IL, IN, KT, MD, ME, MN, MO, MT, NC, NJ, NY, OK, PA, TN, TX, UT, VA, and WI), Belgium…
      Full distribution text Worldwide Distribution -- US (CA, IL, IN, KT, MD, ME, MN, MO, MT, NC, NJ, NY, OK, PA, TN, TX, UT, VA, and WI), Belgium and Japan.
      Submission number: K042357
    • 21 Jul 2008 Z-0225-2009 Unclassified (pre-2012) Terminated BD Diagnostics GeneOhm (BDDG) initiated the recall after they identified that the product has the potential to identify a patient as falsely positive for colonization with methicillin resistant Staphylococcus aureus. The potential health hazard related to a false positive result from this assay would be that a patient may be misclassified as having MRSA colonization when in fact they do not have Distribution: Nationwide to FL, NJ, NY, OH & PA and Internationally to Belgium Submission number: K042357
    • 21 Jul 2008 Z-0226-2009 Unclassified (pre-2012) Terminated BD Diagnostics GeneOhm (BDDG) initiated the recall after they identified that the product has the potential to identify a patient as falsely positive for colonization with methicillin resistant Staphylococcus aureus. The potential health hazard related to a false positive result from this assay would be that a patient may be misclassified as having MRSA colonization when in fact they do not have Distribution: Nationwide to FL, NJ, NY, OH & PA and Internationally to Belgium Submission number: K042357

Frequently asked questions

How many devices does Bd Diagnostics (Geneohm Sciences, Inc.) have in the registry?

The registry currently lists 4 devices for Bd Diagnostics (Geneohm Sciences, Inc.). Devices recorded under merged duplicate company entries are counted once.

Which registries list Bd Diagnostics (Geneohm Sciences, Inc.)'s devices?

Among its 4 most recently registered devices, Bd Diagnostics (Geneohm Sciences, Inc.) has devices listed in FDA 510(k) (4 devices).

What risk classes do Bd Diagnostics (Geneohm Sciences, Inc.)'s devices fall under?

Among its 4 most recently registered devices, the classes recorded for Bd Diagnostics (Geneohm Sciences, Inc.)'s devices are Class I and Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for Bd Diagnostics (Geneohm Sciences, Inc.)?

FDA recall records list 3 recalls initiated by Bd Diagnostics (Geneohm Sciences, Inc.), the most recent initiated on 11 Nov 2008. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Bd Diagnostics (Geneohm Sciences, Inc.) in the registry?

The most recently registered devices listed for Bd Diagnostics (Geneohm Sciences, Inc.) include BD GENEOHM CDIFF ASSAY, BD MAX MRSA ASSAY, BD MAX INSTRUMENT, BD GENEOHM STAPHSR ASSAY and BD GENEOHM MRSA ACP ASSAY.

Generated automatically from registry data and not verified by a human reviewer.